نتایج جستجو برای: cell vaccines

تعداد نتایج: 1721750  

Journal: :The Cochrane database of systematic reviews 2016
Slimane Allali Martin Chalumeau Odile Launay Samir K Ballas Mariane de Montalembert

BACKGROUND People affected with sickle cell disease are at high risk of infection from Haemophilus influenzae type b. Before the implementation of Haemophilus influenzae type b conjugate vaccination in high-income countries, this was responsible for a high mortality rate in children under five years of age. In African countries, where coverage of this vaccination is still extremely low, Haemoph...

Background & Objective: DNA vaccines as a new generation of vaccines require adjuvant to improve vaccine immunogenicity; adjuvants can also increase the DNA vaccine efficacy. In this study, the effects of the host’s interferon-inducible Mx protein as bio adjuvant and conventional alum adjuvant were evaluated.   Materials & Methods: The BALB/c mice were immunized by different prime-boost strate...

2013
Waldely Oliveira Dias Arno A.J. van der Ark Maria Aparecida Sakauchi Flávia Saldanha Kubrusly Ana Fabíola R.O. Prestes Monamaris Marques Borges Noemi Furuyama Denise S.P.Q. Horton Wagner Quintilio Marta Antoniazi Betsy Kuipers Bernard A.M. van der Zeijst Isaias Raw

An improved whole cell pertussis vaccine, designated as Plow, which is low in endotoxicity due to a chemical extraction of lipo-oligosaccharide (LOS) from the outer membrane, was evaluated for safety, immunogenicity and potency, comparatively to a traditional whole cell pertussis vaccine. Current whole cell pertussis vaccines are effective but contain large quantities of endotoxin and consequen...

2012
Sandhiya Selvarajan Melvin George Suresh Kumar Steven Aibor Dkhar

Cancer related deaths have shown a progressive increase over the past decade and the newer cases of cancers are estimated to rise in 2030. The current treatment modalities available for cancer are highly toxic, impair quality of life and develop resistance with course of time. Thus, there is a growing necessity for the prevention and cure of cancer related morbidity and mortality. One of the pr...

2013
Teresa Manzo Rodrigo Hess Michelini Tabea Sturmheit Veronica Basso Matteo Bellone Anna Mondino

Anticancer vaccines hold the potential to promote tumor eradication by immune effector cells. We have recently found dendritic cell-based vaccines to instruct graft-vs.-tumor responses following allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusion. Vaccination was essential to elicit the intratumoral expression of interferon γ, promote local inflammation, and stimula...

2012
Simon H. Apte Penny L. Groves Mariusz Skwarczynski Yoshio Fujita Chenghung Chang Istvan Toth Denise L. Doolan

Vaccines against many pathogens for which conventional approaches have failed remain an unmet public health priority. Synthetic peptide-based vaccines offer an attractive alternative to whole protein and whole organism vaccines, particularly for complex pathogens that cause chronic infection. Previously, we have reported a promising lipid core peptide (LCP) vaccine delivery system that incorpor...

2010
Pascal Feunou Feunou Julie Bertout Camille Locht

BACKGROUND Despite the extensive use of efficacious vaccines, pertussis still ranks among the major causes of childhood mortality worldwide. Two types of pertussis vaccines are currently available, whole-cell, and the more recent acellular vaccines. Because of reduced reactogenicity and comparable efficacy acellular vaccines progressively replace whole-cell vaccines. However, both types require...

Journal: :Cancer research 1997
J W Simons E M Jaffee C E Weber H I Levitsky W G Nelson M A Carducci A J Lazenby L K Cohen C C Finn S M Clift K M Hauda L A Beck K M Leiferman A H Owens S Piantadosi G Dranoff R C Mulligan D M Pardoll F F Marshall

Granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transduced, irradiated tumor vaccines induce potent, T-cell-mediated antitumor immune responses in preclinical models. We report the initial results of a Phase I trial evaluating this strategy for safety and the induction of immune responses in patients with metastatic renal cell carcinoma (RCC). Patients were treated in a randomize...

Journal: :Cancer research 2015
Madiha Derouazi Wilma Di Berardino-Besson Elodie Belnoue Sabine Hoepner Romy Walther Mahdia Benkhoucha Patrick Teta Yannick Dufour Céline Yacoub Maroun Andres M Salazar Denis Martinvalet Pierre-Yves Dietrich Paul R Walker

Vaccines that can coordinately induce multi-epitope T cell-mediated immunity, T helper functions, and immunologic memory may offer effective tools for cancer immunotherapy. Here, we report the development of a new class of recombinant protein cancer vaccines that deliver different CD8(+) and CD4(+) T-cell epitopes presented by MHC class I and class II alleles, respectively. In these vaccines, t...

2012
Verena Lohr Yvonne Genzel Ingo Jordan Dietmar Katinger Stefan Mahr Volker Sandig Udo Reichl

BACKGROUND Current influenza vaccines are trivalent or quadrivalent inactivated split or subunit vaccines administered intramuscularly, or live attenuated influenza vaccines (LAIV) adapted to replicate at temperatures below body temperature and administered intranasally. Both vaccines are considered safe and efficient, but due to differences in specific properties may complement each other to e...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید